Literature DB >> 10494294

Grading of renal cell carcinoma.

N S Goldstein1.   

Abstract

Recognition of the prognostic utility of renal cell carcinoma grading is not a recent development. Most pathologists in the United States use the Fuhrman grading system; however, this system is fraught with limitations and controversies. The Fuhrman grading system makes initial sense and seems simple to apply; however, it is hampered by several limitations, the foremost being that there is no consensus on the prognostic significance of the different grades of renal cell carcinoma.

Entities:  

Mesh：

Year:  1999        PMID： 10494294     DOI： 10.1016/s0094-0143(05)70204-4

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN： 0094-0143            Impact factor:   2.241


  5 in total

1.  Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma.

Authors:  Yasuo Awakura; Eijiro Nakamura; Takeshi Takahashi; Hirokazu Kotani; Yoshiki Mikami; Tadashi Kadowaki; Akira Myoumoto; Hideo Akiyama; Noriyuki Ito; Toshiyuki Kamoto; Toshiaki Manabe; Hitoshi Nobumasa; Gozoh Tsujimoto; Osamu Ogawa
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-16       Impact factor: 4.553

2.  Grade-dependent proteomics characterization of kidney cancer.

Authors:  Bertrand Perroud; Tatz Ishimaru; Alexander D Borowsky; Robert H Weiss
Journal:  Mol Cell Proteomics       Date:  2009-01-21       Impact factor: 5.911

3.  The ISUP system of staging, grading and classification of renal cell neoplasia.

Authors:  Hemamali Samaratunga; Troy Gianduzzo; Brett Delahunt
Journal:  J Kidney Cancer VHL       Date:  2014-07-20

4.  Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma.

Authors:  Hakushi Kim; Chie Inomoto; Takato Uchida; Hiroyuki Furuya; Tomoyoshi Komiyama; Hiroshi Kajiwara; Hiroyuki Kobayashi; Naoya Nakamura; Akira Miyajima
Journal:  Int J Oncol       Date:  2018-02-28       Impact factor: 5.650

5.  Validation of the World Health Organization/International Society of Urological Pathology grading for Chinese patients with clear cell renal cell carcinoma.

Authors:  Qiao Xiao; Xiaoping Yi; Xiao Guan; Hongling Yin; Cikui Wang; Liang Zhang; Yingxian Pang; Minghao Li; Guanghui Gong; Danlei Chen; Longfei Liu
Journal:  Transl Androl Urol       Date:  2020-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.